Gene: SLC41A1
Official Full Name: solute carrier family 41 member 1provided by HGNC
Gene Summary: Enables magnesium:sodium antiporter activity. Involved in cellular response to magnesium ion; intracellular magnesium ion homeostasis; and magnesium ion transmembrane transport. Located in basolateral plasma membrane. Part of protein-containing complex. Implicated in nephronophthisis. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO21148 | SLC41A1 Knockout cell line (HeLa) | Human | SLC41A1 | 1:3~1:6 | Negative | Online Inquiry |
KO21149 | SLC41A1 Knockout cell line (HCT 116) | Human | SLC41A1 | 1:2~1:4 | Negative | Online Inquiry |
KO21150 | SLC41A1 Knockout cell line (HEK293) | Human | SLC41A1 | 1:3~1:6 | Negative | Online Inquiry |
KO21151 | SLC41A1 Knockout cell line (A549) | Human | SLC41A1 | 1:3~1:4 | Negative | Online Inquiry |
SLC41A1 Gene Knockout Cell Lines are genetically engineered cellular models designed to specifically disrupt the SLC41A1 gene, which encodes for a magnesium transporter integral to cellular homeostasis and signaling. These cell lines facilitate the study of the gene's role in various physiological processes, particularly in ion transport, regulation of cellular magnesium levels, and the modulation of cellular responses to environmental stresses.
The key mechanism of action involves targeted gene editing techniques such as CRISPR-Cas9, ensuring a precise knockout of the SLC41A1 gene. This results in the effective abrogation of the gene's expression, allowing researchers to observe subsequent changes in cellular behavior related to magnesium ion transport and to assess the impacts on cellular functions such as metabolism, apoptosis, and cell proliferation. This makes them invaluable for dissecting the molecular pathways influenced by magnesium dysregulation, particularly in the context of diseases like cancer and neurodegenerative disorders.
The scientific importance of these knockout cell lines lies in their ability to serve as powerful tools in both basic research and therapeutic development. They enable researchers to elucidate the contributions of SLC41A1 to various pathophysiological conditions, paving the way for potential therapeutic targets in clinical settings. Furthermore, these models can expedite drug screening processes, contributing to the discovery of novel therapeutic agents aimed at diseases linked to magnesium transport dysfunction.
Unique advantages of our SLC41A1 Gene Knockout Cell Lines include their validated efficacy, reproducible results, and customizable options for various applications. These cell lines excel in consistency, allowing scientists reliable data for longitudinal studies. Compared to alternative methods such as transient transfections or pharmacological inhibitors, knockout cell lines provide a stable platform conducive to long-term experimentation and the investigation of chronic cellular responses.
Researchers, clinicians, and biopharmaceutical industries will find our SLC41A1 Gene Knockout Cell Lines essential in expanding their understanding of ion transport mechanisms and their implications in health and disease. Our company specializes in providing high-quality genetic models, and our expertise in the production of genetically modified cell lines ensures that you will receive not only a highly functional product but also unparalleled support in your research endeavors.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.